Gender differences in metformin effect on aging, life span and spontaneous tumorigenesis in 129/Sv mice
2010
Metformin and its effects on aging in male mice
publication
Evidence: moderate
Author Information
Author(s): Blagosklonny Mikhail V.
Primary Institution: Roswell Park Cancer Institute
Hypothesis
Does metformin have different effects on aging and lifespan in male and female mice?
Conclusion
Metformin may be harmful to young male mice by decreasing their lifespan despite its anti-aging properties.
Supporting Evidence
- Metformin has been shown to slow aging in female mice but not in males.
- Young male mice treated with metformin experienced a 13% decrease in lifespan.
- Inhibition of the mTOR pathway by metformin may contribute to its anti-aging effects.
Takeaway
Metformin, a drug that helps with diabetes, might actually make young male mice live shorter lives, even though it can help other mice live longer.
Limitations
The study may not fully account for environmental factors affecting lifespan.
Participant Demographics
The study involved different strains of mice, focusing on gender differences.
Want to read the original?
Access the complete publication on the publisher's website